These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
479 related articles for article (PubMed ID: 27483368)
1. Adverse Renal, Endocrine, Hepatic, and Metabolic Events during Maintenance Mood Stabilizer Treatment for Bipolar Disorder: A Population-Based Cohort Study. Hayes JF; Marston L; Walters K; Geddes JR; King M; Osborn DP PLoS Med; 2016 Aug; 13(8):e1002058. PubMed ID: 27483368 [TBL] [Abstract][Full Text] [Related]
2. Self-harm, Unintentional Injury, and Suicide in Bipolar Disorder During Maintenance Mood Stabilizer Treatment: A UK Population-Based Electronic Health Records Study. Hayes JF; Pitman A; Marston L; Walters K; Geddes JR; King M; Osborn DP JAMA Psychiatry; 2016 Jun; 73(6):630-7. PubMed ID: 27167638 [TBL] [Abstract][Full Text] [Related]
3. Mortality risk and mood stabilizers in bipolar disorder: a propensity-score-weighted population-based cohort study in 2002-2018. Chan JKN; Wong CSM; Fang CZ; Hung SC; Lo HKY; Chang WC Epidemiol Psychiatr Sci; 2024 May; 33():e31. PubMed ID: 38779809 [TBL] [Abstract][Full Text] [Related]
4. A rapid and systematic review and economic evaluation of the clinical and cost-effectiveness of newer drugs for treatment of mania associated with bipolar affective disorder. Bridle C; Palmer S; Bagnall AM; Darba J; Duffy S; Sculpher M; Riemsma R Health Technol Assess; 2004 May; 8(19):iii-iv, 1-187. PubMed ID: 15147609 [TBL] [Abstract][Full Text] [Related]
5. Bipolar Disorder and Outcomes of Monotherapy with Lithium, Valproate, Quetiapine, Olanzapine, Venlafaxine, and Citalopram. Bohlken J; Riedel-Heller S; Bauer M; Kostev K Pharmacopsychiatry; 2021 May; 54(3):126-130. PubMed ID: 33494115 [TBL] [Abstract][Full Text] [Related]
6. Reducing the rehospitalization risk after a manic episode: A population based cohort study of lithium, valproate, olanzapine, quetiapine and aripiprazole in monotherapy and combinations. Wingård L; Bodén R; Brandt L; Tiihonen J; Tanskanen A; Kieler H; Andersen M; Reutfors J J Affect Disord; 2017 Aug; 217():16-23. PubMed ID: 28364619 [TBL] [Abstract][Full Text] [Related]
8. Cost effectiveness of adjunctive quetiapine fumarate extended-release tablets with mood stabilizers in the maintenance treatment of bipolar I disorder. Woodward TC; Tafesse E; Quon P; Lazarus A Pharmacoeconomics; 2010; 28(9):751-64. PubMed ID: 20623994 [TBL] [Abstract][Full Text] [Related]
9. Lithium vs. valproate vs. olanzapine vs. quetiapine as maintenance monotherapy for bipolar disorder: a population-based UK cohort study using electronic health records. Hayes JF; Marston L; Walters K; Geddes JR; King M; Osborn DP World Psychiatry; 2016 Feb; 15(1):53-8. PubMed ID: 26833609 [TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of quetiapine plus mood stabilizers compared with mood stabilizers alone in the maintenance therapy of bipolar I disorder: results of a Markov model analysis. Fajutrao L; Paulsson B; Liu S; Locklear J Clin Ther; 2009 Jun; 31 Pt 1():1456-68. PubMed ID: 19698903 [TBL] [Abstract][Full Text] [Related]
11. Lithium for acute mania. McKnight RF; de La Motte de Broöns de Vauvert SJGN; Chesney E; Amit BH; Geddes J; Cipriani A Cochrane Database Syst Rev; 2019 Jun; 6(6):CD004048. PubMed ID: 31152444 [TBL] [Abstract][Full Text] [Related]
12. The efficacy and safety of switching to ziprasidone from olanzapine in patients with bipolar I disorder: an 8-week, multicenter, open-label study. Lee HB; Yoon BH; Kwon YJ; Woo YS; Lee JG; Kim MD; Bahk WM Clin Drug Investig; 2013 Oct; 33(10):743-53. PubMed ID: 23990283 [TBL] [Abstract][Full Text] [Related]
13. Treatment of bipolar depression: making sensible decisions. Citrome L CNS Spectr; 2014 Dec; 19 Suppl 1():4-11; quiz 1-3, 12. PubMed ID: 25407667 [TBL] [Abstract][Full Text] [Related]
15. A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder. Soares-Weiser K; Bravo Vergel Y; Beynon S; Dunn G; Barbieri M; Duffy S; Geddes J; Gilbody S; Palmer S; Woolacott N Health Technol Assess; 2007 Oct; 11(39):iii-iv, ix-206. PubMed ID: 17903393 [TBL] [Abstract][Full Text] [Related]
16. Effectiveness of mood stabilizers and antipsychotics in the maintenance phase of bipolar disorder: a systematic review of randomized controlled trials. Smith LA; Cornelius V; Warnock A; Bell A; Young AH Bipolar Disord; 2007 Jun; 9(4):394-412. PubMed ID: 17547586 [TBL] [Abstract][Full Text] [Related]
17. Pharmacological prevention of mood episodes in women with bipolar disorder during the perinatal period: A systematic review of current literature. Uguz F Asian J Psychiatr; 2020 Aug; 52():102145. PubMed ID: 32516746 [TBL] [Abstract][Full Text] [Related]